Post by
HopefulJuan on Nov 21, 2017 6:25pm
Current Book Value
Book value / share for CMED is $3.96 vs .60 for ACB would imply a value factor of 6.6
Price / Sales is 126 for ACB to 29.68 for CMED, Price / Book is 10.1 for ACB to 4.97 for CMED.
Seems like smoke and mirrors in play.
CMED does not need ACB imo
Comment by
Extalliones on Nov 21, 2017 7:13pm
Gotta be honest I understand next to none of that.
Comment by
HopefulJuan on Nov 21, 2017 7:29pm
May I ask what logic you base your investment decisions on ?
Comment by
Rockpaperstock on Nov 21, 2017 8:27pm
That's funny. Yeah, not understanding P/B ratio.... living dangerously mate! It's not voodoo, Google is your friend. P/B for WEED is 4.9, APH 4.1....if we can compare ourselves to those 2, seems like we're not too overvalued (vs ACB at 9.3)
Comment by
makingmoney1 on Nov 21, 2017 9:09pm
This post has been removed in accordance with Community Policy
Comment by
bluevelvet on Nov 21, 2017 9:29pm
I wouldn't buy at this current price either. But I definitely see the potential of the company. Would definitely buy a lot more stock if it drops back to $3 -- not convinced that will happen though, yet. But I'm learning this industry is not all that predictable to say the least.
Comment by
bluevelvet on Nov 21, 2017 11:21pm
I personally think if the takeover doesn't happen that my investiment in ACB will be kind of messed up.
Comment by
GR8BALLS on Nov 21, 2017 7:22pm
I hoped that CMED would remain on its own at least for a couple more years. I see ACB moving up today and CMED staying down... manipulation ... what can we do. I would appreciate 30 dollars per share but it ain’t gonna happen